Pauline E Jolly
Overview
Explore the profile of Pauline E Jolly including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
90
Citations
1512
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jolly P, Li Y, Thomas A, Braun A, Padilla L, Thompson S, et al.
J Infect Prev
. 2024 Nov;
25(6):214-224.
PMID: 39493588
Objectives: The emergence of deadly infections such as methicillin-resistant and COVID-19 () highlights the need for effective infection control (IC) procedures in healthcare facilities. The aim of the study was...
2.
Lestari D, Wellere A, Brill I, Sari N, Jolly P, Piyathilake C
Int J Womens Health
. 2024 Oct;
16:1677-1685.
PMID: 39403273
Background: The burden of Human papillomavirus (HPV)-related cancers is expected to rise in Indonesia as there has been an increase in the availability of medication that prolongs the survival of...
3.
Datnow-Martinez C, Ransom B, Niranjan S, Howard C, Aung M, Jolly P
Int Breastfeed J
. 2024 Sep;
19(1):63.
PMID: 39261855
Background: Despite the many benefits of exclusive breastfeeding to infants and mothers, only 33% of Jamaican infants are exclusively breastfed up to the recommend six months. This study was conducted...
4.
Understanding female sex workers' acceptance of secret Facebook group for HIV prevention in Cameroon
Blake H, Njah M, Babey M, Asongwe E, Junkins A, Dionne J, et al.
PLOS Digit Health
. 2024 Aug;
3(8):e0000562.
PMID: 39141653
Despite the widespread utilization of social media in HIV prevention interventions, little is known about the acceptance of social media in the dissemination of HIV prevention information among key at-risk...
5.
Jolly P, Junkins A, Aung M
Infect Agent Cancer
. 2023 Sep;
18(1):53.
PMID: 37742036
Background: About 90% of new cervical cancer cases and deaths worldwide in 2020 occurred in low- and middle-income countries. This can be attributed to the low rates of cervical cancer...
6.
Piyathilake C, Badiga S, Thao N, Jolly P
Korean J Community Nutr
. 2023 Sep;
28(1):61-73.
PMID: 37674548
Objectives: Prophylactic vaccines against high-risk human papillomaviruses (HR-HPVs) hold promise to prevent the development of higher grade cervical intraepithelial neoplasia (CIN 2+) and cervical cancer (CC) that develop due to...
7.
Piyathilake C, Badiga S, Jolly P
Cancer Prev Res (Phila)
. 2023 Jan;
:OF1-OF10.
PMID: 36657016
Prevention Relevance: This study documents the concerns of the age-based changes in screening guidelines on the identification of higher grades of cervical intraepithelial neoplasia and their determinants in women diagnosed...
8.
Piyathilake C, Badiga S, Jolly P
Cancer Prev Res (Phila)
. 2022 Dec;
PMID: 36474315
Current American Cancer Society (ACS) guidelines estimated that screening starting at the age of 25 years with Pap and/or human papillomavirus (HPV) testing is sufficient to prevent cervical cancer (CC)....
9.
Piyathilake C, Badiga S, Hernandez A, Brill I, Jolly P
Nutr Metab Cardiovasc Dis
. 2022 Mar;
32(6):1385-1391.
PMID: 35282985
Background And Aims: Adequate dietary intakes of essential micronutrients are critical to prevent insulin resistance (IR)-related diseases. Even though the excess calorie intake linked with obesity is also associated with...
10.
Piyathilake C, Badiga S, Simons J, Bell W, Jolly P
Int J Womens Health
. 2022 Feb;
14:257-266.
PMID: 35221728
Objective: Since a quantitative polymerase chain reaction (qPCR) assay targeting the E1 region of HPV genome is cost-effective/simple to perform, we evaluated the agreement between the Roche Diagnostics Linear Array...